| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |